SCHEMBL9518012

SCHEMBL9518012

O=CCCC(c1ccc(F)cc1)S(=O)(=O)NC(=O)c1ccc(CO)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
EPHX2 P34913 7/20 0.36
HDAC6 Q9UBN7 3/20 0.36
P4HTM Q9NXG6 2/20 0.36
HDAC3 O15379 2/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC2 Q92769 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CYP2J2 P51589 1/20 0.36
HDAC4 P56524 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9515891 0.90 EGFR (0.41) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9515632 0.90 MEN1 (0.38) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9515967 0.89 HIF1A (0.38) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9515545 0.88 HDAC6 (0.36) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9515522 0.86 LMNA (0.37) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9519311 0.86 P4HTM (0.36) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9516127 0.85 MMP1 (0.37) MEN1NPC1RAB9AKMT2AP4HTM
SCHEMBL9518019 0.83 MEN1 (0.39) MEN1NPC1RAB9AKMT2AL3MBTL1
SCHEMBL9515429 0.82 HDAC1 (0.38) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL9515435 0.80 P4HTM (0.40) MEN1NPC1RAB9AKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed